Explore the Demand for Keloid Treatment in Japan — analysis of key trends, regional growth, top players, and a 10-year forecast from 2026 to 2036

Future Market Insights

Demand for Keloid Treatment in Japan

Key Insight

The demand for keloid treatment in Japan is projected to grow from USD 189.3 million in 2025 to USD 250.7 million by 2035, at a CAGR of 2.9%. Intralesional Corticosteroid Injections will dominate with a 22.0% market share, while hospitals will lead the end user segment with a 45.0% share.

January 05, 2026

Anurag Sharma

250 Pages

Cite this Report

Demand for Keloid Treatment in Japan

https://www.futuremarketinsights.com/reports/japan-keloid-treatment-market

License

Starting at US$ 5000

Buy Now

Summary ToC Companies

Key Players

Bristol-Myers Squibb
Novartis
Perrigo Company plc
RXi Pharmaceuticals Inc
Sensus Healthcare

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Demand for Keloid Treatment in Japan

Key Players

Similar Industry Reports